Fake Banner
Vaccination Opponents Drive An Epidemic Of COVID-19 Misinformation

There is a saying that when all you have is a hammer, everything looks like a nail. So, it should...

Will COVID-19 Use Myocarditis To Strike Out Baseball?

By Glen Pyle and Gurkiran Dhuga COVID-19 has thrown professional baseball in North America a...

A False Start For Women: Why Are Women With Cardiovascular Disease Undertreated?

by Gurkiran Dhuga&Glen Pyle The fight for equality between the sexes has undoubtedly made...

Is Air Pollution The Next Pandemic? How Air Quality Increases Deaths From Cardiovascular Disease

By Gurkiran Dhuga and Glen Pyle Throughout the last few decades health concerns related to air...

User picture.
W. Glen PyleRSS Feed of this column.

W. Glen Pyle, PhD is a Professor in the Department of Biomedical Sciences at the University of Guelph and an Associate Member of the IMPART Team Canada Investigator Network at Dalhousie Medicine... Read More »

As the search for an effective COVID19 treatment goes on, one therapy keeps re-appearing in the headlines: hydroxychloroquine. Early, observational studies on the use of hydroxychloroquine to treat patients with COVID19 failed to show any real benefits of the drug. The ability of hydroxychloroquine to prevent the development of COVID19, however, remained largely untested. But a study on the effectiveness of hydroxychloroquine to prevent COVID19 has been published and the results are not what anyone was hoping for.

The Set-Up

The antimalarial drug hydroxychloroquine, touted as a miracle cure for COVID-19, appeared to have had it’s Titanic moment, at least according to a study published in the Lancet. The retrospective study analyzed the records of patients from 6 continents and found that not only was hydroxychloroquine not an effective treatment, its cardiac side effects were potentially dangerous. But this was just the tip of the iceberg, and the results were disastrous.

The Study

Co-authored by by Lauren Philippi, Department of Human Health and Nutritional Sciences, University of Guelph

In late December 2019 an outbreak of pneumonia cases arose in Wuhan, China. Patients presented with an acute respiratory illness linked to the 2019 Novel Coronavirus (COVID-19). COVID-19 is a betacoronavirus, similar to Human Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) coronaviruses. SARS and MERS both cause severe respiratory disease. Although COVID-19 is primarily considered a respiratory virus, there is a strong link to cardiovascular disease.

COVID-19 — by the numbers